Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Graphite Bio's Pre-Tax Income for the
three
months ended in Dec. 2023 was $-22.92 Mil. Graphite Bio's Revenue for the
three
months ended in Dec. 2023 was $0.00 Mil. Therefore, Graphite Bio's pretax margin for the quarter that ended in Dec. 2023 was %.
The historical rank and industry rank for Graphite Bio's Pretax Margin % or its related term are showing as below:
GRPH's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -155.98 * Ranked among companies with meaningful Pretax Margin % only.
Graphite Bio Pretax Margin % Historical Data
The historical data trend for Graphite Bio's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Graphite Bio's Pretax Margin %
For the Biotechnology subindustry, Graphite Bio's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Graphite Bio's Pretax Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Graphite Bio's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Graphite Bio's Pretax Margin % falls into.
Graphite Bio Pretax Margin % Calculation
Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.
Graphite Bio's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Graphite Bio (NAS:GRPH) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Graphite Bio Pretax Margin % Related Terms
Thank you for viewing the detailed overview of Graphite Bio's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire disease-causing genes with normal genes, or insert new genes into predetermined, safe locations. Its product candidate GPH101 is a differentiated approach with the potential to directly correct the mutation that causes sickle cell disease (SCD) and restore normal adult hemoglobin (HgbA) expression. All of the company's long-lived assets are based in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GRPH has been successfully added to your 